Skip to content

Thymatron

by Somatics, Inc.

510(k) K843923

Thymatron is a medical device (FDA Class II; FDA product code QGH) made by Somatics, Inc., cleared under FDA 510(k) K843923 on 3 Dec 1984, active as of 11 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 11 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 11 Oct 2026.

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK843923 Date3 Dec 1984ClearedStatusActive

Official records

From the FDA record

Received by the FDA
5 Oct 1984
FDA decision
3 Dec 1984 (Substantially Equivalent)
FDA review time
59 days from receipt to decision

From the FDA 510(k) record K843923 (openFDA), as read on 11 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
QGH
Device class
Class II
Regulation
21 CFR Part 882.5940
Advisory committee
Neurology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code QGH (Electroconvulsive Therapy Device For Catatonia, Major Depressive Disorder, And Bipolar Disorder).

Other devices from Somatics, LLC

See all devices from Somatics, LLC →